Gimlet Labs
Gimlet Labs Raises $300M Series B at a $3B Valuation
Gimlet Labs announced $300M in Series B financing on September 4, 2026. Gimlet Labs raised a $300 million Series B led by Andreessen Horowitz for its multi-silicon inference cloud, bringing total funding to $392 million.
Round details
The financing includes backing from Andreessen Horowitz, Sapphire Ventures, M12, Arm. The company reported a $3B valuation alongside the transaction.
- Round: Series B
- Capital announced: $300M
- Total funding reported: $392M
- Headquarters: San Francisco, CA
How the company plans to use the capital
Gimlet will build out operations for its managed multi-silicon inference cloud and expand its team as it scales heterogeneous infrastructure across GPUs, CPUs, and purpose-built accelerators.
Why this matters for GTM teams
The financing highlights growing demand for inference platforms that optimize workloads across different chip architectures to improve throughput, latency, and energy efficiency.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Gimlet Labs Series B announcement.
Company Info
Investors (4)
Share
Related Reports
Armadin Raises $255.5M Series B for Autonomous Security
Armadin raised a $255.5 million Series B co-led by Andreessen Horowitz and Accel to scale its agentic security platform and its research, training, and go-to-market efforts.
Homeward Raises $120M Series D for Cash Offer and Bridge Financing
Homeward raised a $120 million Series D led by Saluda Grade, plus $330 million in asset-backed debt, to expand cash offer and bridge financing for real estate agents.
Varda Raises $251M Series D for Space-Based Pharmaceutical Processing
Varda Space Industries raised a $251 million Series D led by Lux Capital and Natural Capital to scale space-based pharmaceutical processing.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free